North America Sarcopenia Treatment Market : Table of Contents

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. North America Sarcopenia Treatment Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. North America Sarcopenia Treatment Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. North America Sarcopenia Treatment Market Regional Analysis

6.2 North America Sarcopenia Treatment Market Revenue 2020-2030 (US$ Million)

6.3 North America Sarcopenia Treatment Market Forecast Analysis

7. North America Sarcopenia Treatment Market Analysis – by Treatment Type

7.1 Vitamin D and Calcium Supplement

7.1.1 Overview
7.1.2 Vitamin D and Calcium Supplement: North America Sarcopenia Treatment Market – Revenue and Forecast, 2020-2030 (US$ Million)

7.2 Protein Supplement

7.2.1 Overview
7.2.2 Protein Supplement: North America Sarcopenia Treatment Market – Revenue and Forecast, 2020-2030 (US$ Million)

7.3 Vitamin B12 Supplement

7.3.1 Overview
7.3.2 Vitamin B12 Supplement: North America Sarcopenia Treatment Market – Revenue and Forecast, 2020-2030 (US$ Million)

8. North America Sarcopenia Treatment Market Analysis – by Distribution Channel

8.1 Pharmacies

8.1.1 Overview
8.1.2 Pharmacies: North America Sarcopenia Treatment Market – Revenue and Forecast, 2020-2030 (US$ Million)

8.2 Retail Channels

8.2.1 Overview
8.2.2 Retail Channels: North America Sarcopenia Treatment Market – Revenue and Forecast, 2020-2030 (US$ Million)

8.3 Online Channels

8.3.1 Overview
8.3.2 Online Channels: North America Sarcopenia Treatment Market – Revenue and Forecast, 2020-2030 (US$ Million)

9. North America Sarcopenia Treatment Market – North America Analysis

9.1 Overview

9.2 North America

9.2.1 North America Sarcopenia Treatment Market Breakdown, by Key Country, 2023 and 2030 (%)
9.2.1.1 North America Sarcopenia Treatment Market – Revenue and Forecast Analysis – by Country
9.2.1.1 US: North America Sarcopenia Treatment Market – Revenue and Forecast to 2030 (US$ Million)

9.2.1.1.1 US: North America Sarcopenia Treatment Market Breakdown, by Treatment Type
9.2.1.1.2 US: North America Sarcopenia Treatment Market Breakdown, by Distribution Channel

9.2.1.2 Canada: North America Sarcopenia Treatment Market – Revenue and Forecast to 2030 (US$ Million)

9.2.1.2.1 Canada: North America Sarcopenia Treatment Market Breakdown, by Treatment Type
9.2.1.2.2 Canada: North America Sarcopenia Treatment Market Breakdown, by Distribution Channel

9.2.1.3 Mexico : North America Sarcopenia Treatment Market – Revenue and Forecast to 2030 (US$ Million)

9.2.1.3.1 Mexico : North America Sarcopenia Treatment Market Breakdown, by Treatment Type
9.2.1.3.2 Mexico : North America Sarcopenia Treatment Market Breakdown, by Distribution Channel

10. Competitive Landscape

10.1 Heat Map Analysis

10.2 Company Positioning and Concentration

11. Industry Landscape

11.1 Overview

11.2 Market Initiative

11.3 Partnerships and Collaborations

11.4 Other Developments

12. Company Profiles

12.1 Abbott Laboratories

12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments

12.2 Bayer AG

12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments

12.3 Metagenics LLC

12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments

12.4 Nestle Health Science SA

12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments

12.5 Novartis AG

12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments

12.6 Pfizer Inc

12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments

12.7 Sanofi SA

12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments

12.8 Amway Corp

12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments

12.9 GSK Plc

12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments

12.10 Makers Nutrition LLC

12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments

13. Appendix

13.1 About Business Market Insights

13.2 List of Abbreviations

North America Sarcopenia Treatment Market

Analysis - by Treatment Type (Vitamin D and Calcium Supplement, Protein Supplement, Vitamin B12 Supplement, and Others) and Distribution Channel (Pharmacies, Retail Channels, Online Channels, and Others)